Clinical Trial: A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-segmental Vitiligo
Study Type: INTERVENTIONAL
Official Title: A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants With Non-Segmental Vitiligo
Brief Summary:
The purpose of this study is to evaluate the efficacy, safety, and tolerability of MK-6194 in participants with non-segmental vitiligo.The primary hypothesis is that at least 1 MK-6194 dose is superior to placebo with regards to percent change from baseline in Facial Vitiligo Area Scoring Index (F-VASI) at Week 24.
Read more